R21/Matrix-M is a significant new vaccine developed for the prevention of Malaria. The R21 vaccine component was developed by the University of Oxford, and it uses Novavax's Matrix-M™ adjuvant technology. The vaccine is manufactured by the Serum Institute of India (SII) under license from the University of Oxford. It has received approval for use in several African countries and prequalification from the World Health Organization (WHO).
What is R21/Matrix-MTM?
Asked in UPPCS Prelims 2024 · Topic: Diseases and Treatment (Vaccination: Principles, Types of Vaccines, and Immunization Programs)
Show answer
Answer: A. Vaccine against Malaria developed by Serum Institute of India
More Biology questions
- Which of the following is mRNA vaccine used against Covid-19 infection?
- Which type of vaccine protect against Diphtheria?
- Vaccination involves :
- What is the importance of using Pneumococcal Conjugate Vaccines in India ?
- In the context of vaccines manufactured to prevent COVID-19 pandemic, consider the following statements: The Serum Institute of India produced COVID-19 vaccine named Covishield using mRNA platform. Sputnik V vaccine is manufactured using vector based platform. COVAXIN is an inactivated pathogen based vaccine. Which of the statements given above are correct ?
- The vaccine for Polio was first prepared by:
- D.T. P. vaccine is given to protect from
- The vaccine for Hepatitis – B Birth dose administered through which route? (1) Intramuscular (2) Intradermal (3) Subcutaneous (4) Oral (5) Question not attempted